Return-Path: <bounce-mc.us2_5169274.1460319-3507c8b6d9@mail61.atl281.mcsv.net>
Received: from gator4148.hostgator.com
	by gator4148.hostgator.com with LMTP
	id gN9dLlcmbWNxkQQA7/vpDg
	(envelope-from <bounce-mc.us2_5169274.1460319-3507c8b6d9@mail61.atl281.mcsv.net>); Thu, 10 Nov 2022 10:27:03 -0600
Return-path: <bounce-mc.us2_5169274.1460319-3507c8b6d9@mail61.atl281.mcsv.net>
Envelope-to: gloria@caldonbiotech.com
Delivery-date: Thu, 10 Nov 2022 10:27:03 -0600
Received: from mail61.atl281.mcsv.net ([198.2.143.61]:46819)
	by gator4148.hostgator.com with esmtps  (TLS1.2) tls TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384
	(Exim 4.95)
	(envelope-from <bounce-mc.us2_5169274.1460319-3507c8b6d9@mail61.atl281.mcsv.net>)
	id 1otAON-001RPf-At
	for gloria@caldonbiotech.com;
	Thu, 10 Nov 2022 10:27:03 -0600
DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed; d=captodayonline.com;
	s=k1; t=1668097612; x=1668400012; i=noreply@captodayonline.com;
	bh=rIP1F0iK2bggPCZJAOD3i3ZhnaWehp3nAOrUZKn3V58=;
	h=Subject:From:Reply-To:To:Date:Message-ID:X-MC-User:Feedback-ID:
	 List-ID:List-Unsubscribe:List-Unsubscribe-Post:Content-Type:
	 MIME-Version:CC:Date:Subject:From;
	b=HgxZf9ZZXTbe7BcPhkmutBStqGdDg+5FtjLKlm5cR9JQ4OaAfsIMwOS7VNT9K7lXj
	 1cvZsbtCQZJ7OK1R5PeIFlbc0ZqClpmF5P4KTrAd9Lbu3PvQP3wIF2aWzj41FApTJQ
	 xBBDwl2oC5aPhBtqxZakYUT7/tgljy6cUHBS5+AQ=
Received: from localhost (localhost [127.0.0.1])
	by mail61.atl281.mcsv.net (Mailchimp) with ESMTP id 4N7S0D5fTszLfYrLr
	for <gloria@caldonbiotech.com>; Thu, 10 Nov 2022 16:26:52 +0000 (GMT)
Subject: =?utf-8?Q?Your=20Respiratory=20reCAP?=
From: =?utf-8?Q?CAP=20TODAY?= <noreply@captodayonline.com>
Reply-To: =?utf-8?Q?CAP=20TODAY?= <noreply@captodayonline.com>
To: =?utf-8?Q?Gloria=20Milich?= <gloria@caldonbiotech.com>
Date: Thu, 10 Nov 2022 16:26:51 +0000
Message-ID: <93f21bea2e282733bd0cd8d59.3507c8b6d9.20221110162643.a959238978.ce771744@mail61.atl281.mcsv.net>
X-Mailer: Mailchimp Mailer - **CIDa9592389783507c8b6d9**
X-Campaign: mailchimp93f21bea2e282733bd0cd8d59.a959238978
X-campaignid: mailchimp93f21bea2e282733bd0cd8d59.a959238978
X-Report-Abuse: Please report abuse for this campaign here: https://mailchimp.com/contact/abuse/?u=93f21bea2e282733bd0cd8d59&id=a959238978&e=3507c8b6d9
X-MC-User: 93f21bea2e282733bd0cd8d59
Feedback-ID: 5169274:5169274.1460319:us2:mc
List-ID: 93f21bea2e282733bd0cd8d59mc list <93f21bea2e282733bd0cd8d59.778753.list-id.mcsv.net>
X-Accounttype: pr
List-Unsubscribe: <https://captodayonline.us2.list-manage.com/unsubscribe?u=93f21bea2e282733bd0cd8d59&id=1abd017e9e&e=3507c8b6d9&c=a959238978>, <mailto:unsubscribe-mc.us2_93f21bea2e282733bd0cd8d59.a959238978-3507c8b6d9@unsubscribe.mailchimpapp.net?subject=unsubscribe>
List-Unsubscribe-Post: List-Unsubscribe=One-Click
Content-Type: multipart/alternative; boundary="_----------=_MCPart_2086185115"
MIME-Version: 1.0
X-Spam-Status: No, score=2.5
X-Spam-Score: 25
X-Spam-Bar: ++
X-Spam-Flag: NO

This is a multi-part message in MIME format

--_----------=_MCPart_2086185115
Content-Type: text/plain; charset="utf-8"; format="fixed"
Content-Transfer-Encoding: quoted-printable

Influenza incidence and what it will mean for testing in this respiratory=
 virus season is a wild card=2C as is how SARS-CoV-2 will evolve.

https://www.captodayonline.com
Your Respiratory reCAP


** Webinar:
=E2=80=9CWhat's Next? Transitioning from EUA to IVD for SARS-CoV-2=E2=80=
=9D (https://urldefense.com/v3/__https://youtu.be/bL6VSQ-KzOQ__;!!Nge-QFtC=
GiqLqA!DSCyGRUJatABaHtT1a20pLonVu4Vy1E_6OSbf-FjcsgF_s1HDCpq2TwiWXBM5cqG___=
b2j84F3U$)
------------------------------------------------------------
This webinar recording provides laboratories a manufacturer-agnostic=2C CA=
P and NY State perspective on the transition from EUA to 510k assays for S=
ARS-CoV=E2=80=932. The focus is on moderate and high complexity=2C molecul=
ar microbiology laboratories to help labs begin thinking through scenarios=
 and important considerations for these upcoming transitions.

Viewers will:
* Develop an understanding of EUA and IVD regulations
* Review validation requirements for EUA and IVD assays=2C including modif=
ied EUAs/IVDs
* Hear discussion about the process for transitioning to IVD assays from E=
UA assays.

Speakers:
David Peaper=2C MD=2C Ph.D.
Associate Professor or Laboratory Medicine; Director=2C Clinical Microbiol=
ogy Laboratory=2C YNHH; Director Medical Microbiology Fellowship Program;=
 Director=2C Virology Reference Laboratory VACT

Kimberlee Musser=2C Ph.D.
New York State Department of Health Wadsworth Center=2C David Axelrod Inst=
itute

------------------------------------------------------------
https://usinfo.roche.com/respiratory_season_q3.html?utm_source=3Dcap_today=
&utm_medium=3Ddigital&utm_campaign=3Dmd_poc-respiratory_season_2022-q4&utm=
_content=3Dfull-na-shortlink&utm_term=3Dna
Roche receives EUA for Cobas SARS-CoV-2 Duo (https://www.captodayonline.co=
m/roche-receives-eua-for-cobas-sars-cov-2-duo/) Roche announced that the F=
DA issued emergency use authorization for the Cobas SARS-CoV-2 Duo for use=
 on the fully automated Cobas 6800/8800 systems. The real-time RT-PCR assa=
y is for the in vitro qualitative and quantitative detection of SARS-CoV-2=
 RNA in nasal and nasopharyngeal swab specimens.

------------------------------------------------------------
https://usinfo.roche.com/respiratory_season_q3.html?utm_source=3Dcap_today=
&utm_medium=3Ddigital&utm_campaign=3Dmd_poc-respiratory_season_2022-q4&utm=
_content=3Dfull-na-shortlink&utm_term=3Dna
A wait-and-watch season of respiratory viruses (https://www.captodayonline=
=2Ecom/a-wait-and-watch-season-of-respiratory-viruses/) Influenza incidence=
 and what it will mean for testing in this respiratory virus season is a w=
ild card=2C as is how SARS-CoV-2 will evolve. In early September=2C SARS-C=
oV-2 prevalence was declining in parts of the United States. =E2=80=9CAnd=
 if you believe in the theory of viral interference=2C=E2=80=9D says Miche=
lle Tabb=2C PhD=2C chief scientific officer at DiaSorin Molecular=2C =E2=
=80=9Cit=E2=80=99s leaving the door wide open right now for something else=
 to step in. We=E2=80=99ll see if that=E2=80=99s RSV=2C or flu A=2C or if=
 it=E2=80=99s a new COVID variant.=E2=80=9D

Australia saw an early peak in influenza and the highest it has seen in ab=
out half a decade=2C simultaneous with COVID=2C says David Persing=2C MD=
=2C PhD=2C chief scientific officer at Cepheid. Public health advisors wor=
ry the same could happen in the Northern Hemisphere. =E2=80=9CThe concern=
 is we=E2=80=99re going to have a surge in influenza and an ongoing level=
 of COVID activity that will combine to create a pretty consequential resp=
iratory season=2C=E2=80=9D Dr. Persing says. Furthermore=2C with fewer exp=
osed to influenza over the past two years=2C =E2=80=9Cthe lack of natural=
 immunity could create a condition in which we have more severe cases=2C o=
r more cases overall=2C and that=E2=80=99s what everybody is afraid of.=E2=
=80=9D

Australia=E2=80=99s statistics=2C while concerning=2C could reflect some a=
mount of ascertainment bias=2C says Daniel Rhoads=2C MD=2C assistant profe=
ssor and section head of microbiology at the Cleveland Clinic. =E2=80=9CPe=
ople are getting tested more now than they did pre-COVID when they have a=
 respiratory virus=2C=E2=80=9D he says. =E2=80=9CSo I think we=E2=80=99re=
 going to detect more influenza=2C and we have to keep in mind that increa=
sed testing is going to lead to increased detection.=E2=80=9D

=C2=A9 2022 CAP TODAY=2C all rights reserved. The appearance of advertisin=
g in this message is not a CAP guarantee or endorsement of the product or=
 the claims made for the product by the manufacturer.

This email was sent to gloria@caldonbiotech.com (mailto:gloria@caldonbiotech.com)
why did I get this? (https://captodayonline.us2.list-manage.com/about?u=3D=
93f21bea2e282733bd0cd8d59&id=3D1abd017e9e&e=3D3507c8b6d9&c=3Da959238978)   =
  unsubscribe from this list (https://captodayonline.us2.list-manage.com/u=
nsubscribe?u=3D93f21bea2e282733bd0cd8d59&id=3D1abd017e9e&e=3D3507c8b6d9&c=3D=
a959238978)     update subscription preferences (https://captodayonline.us=
2.list-manage.com/profile?u=3D93f21bea2e282733bd0cd8d59&id=3D1abd017e9e&e=
=3D3507c8b6d9&c=3Da959238978)
CAP TODAY . 325 Waukegan Road . Northfield=2C IL 60093 . USA
--_----------=_MCPart_2086185115
Content-Type: text/html; charset="utf-8"
Content-Transfer-Encoding: quoted-printable

<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www=
=2Ew3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<!doctype html>
<html>
    <head>
    <meta charset=3D"UTF-8">
    <!-- utf-8 works for most cases -->
    <meta name=3D"viewport" content=3D"width=3Ddevice-width=2C initial-sca=
le=3D1.0">
    <!-- Forcing initial-scale shouldn't be necessary -->
    <meta http-equiv=3D"X-UA-Compatible" content=3D"IE=3Dedge">
    <!-- Use the latest (edge) version of IE rendering engine -->

    <!-- The title tag shows in email notifications=2C like Android 4.4. -=
->
    <!-- Please use an inliner tool to convert all CSS to inline as inpage=
 or external CSS is removed by email clients -->
    <!-- important in CSS is used to prevent the styles of currently inlin=
e CSS from overriding the ones mentioned in media queries when correspondi=
ng screen sizes are encountered -->

    <!-- CSS Reset -->
    <style type=3D"text/css">
/* What it does: Remove spaces around the email design added by some email=
 clients. */
      /* Beware: It can remove the padding / margin and add a background c=
olor to the compose a reply window. */
html=2C  body {
=09margin: 0 !important;
=09padding: 0 !important;
=09height: 100% !important;
=09width: 100% !important;
}
/* What it does: Stops email clients resizing small text. */
* {
=09-ms-text-size-adjust: 100%;
=09-webkit-text-size-adjust: 100%;
}
/* What it does: Forces Outlook.com to display emails full width. */
=2EExternalClass {
=09width: 100%;
}
/* What is does: Centers email on Android 4.4 */
div[style*=3D"margin: 16px 0"] {
=09margin: 0 !important;
}
/* What it does: Stops Outlook from adding extra spacing to tables. */
table=2C  td {
=09mso-table-lspace: 0pt !important;
=09mso-table-rspace: 0pt !important;
}
/* What it does: Fixes webkit padding issue. Fix for Yahoo mail table alig=
nment bug. Applies table-layout to the first 2 tables then removes for any=
thing nested deeper. */
table {
=09border-spacing: 0 !important;
=09border-collapse: collapse !important;
=09table-layout: fixed !important;
=09margin: 0 auto !important;
}
table table table {
=09table-layout: auto;
}
/* What it does: Uses a better rendering method when resizing images in IE=
=2E */
img {
=09-ms-interpolation-mode: bicubic;
}
/* What it does: Overrides styles added when Yahoo's auto-senses a link. *=
/
=2Eyshortcuts a {
=09border-bottom: none !important;
}
/* What it does: Another work-around for iOS meddling in triggered links.=
 */
a[x-apple-data-detectors] {
=09color: inherit !important;
}
</style>

    <!-- Progressive Enhancements -->
    <style type=3D"text/css">
=09=09
=09=09h1 {
=09=09=09font-size:20px;
=09=09=09font-weight:normal;
=09=09=09line-height:25px;
=09=09}
=09=09
=09=09h2 {
=09=09=09font-size:16px;
=09=09=09font-weight:normal;
=09=09=09line-height:22px;
=09=09=09padding-bottom:5px;
=09=09=09margin:0;
=09=09=09
=09=09}
=09=09
=09=09a {
=09=09=09text-decoration:none;
=09=09=09color:#15377e;
=09=09=09padding:0;
=09=09=09margin:0;
=09=09=09
=09=09}

        /* What it does: Hover styles for buttons */
        .button-td=2C
        .button-a {
            transition: all 100ms ease-in;
        }
        .button-td:hover=2C
        .button-a:hover {
            background: #555555 !important;
            border-color: #555555 !important;
        }

        /* Media Queries */
        @media screen and (max-width: 600px) {

            .email-container {
                width: 100% !important;
            }

            /* What it does: Forces elements to resize to the full width o=
f their container. Useful for resizing images beyond their max-width. */
            .fluid=2C
            .fluid-centered {
                max-width: 100% !important;
                height: auto !important;
                margin-left: auto !important;
                margin-right: auto !important;
            }
            /* And center justify these ones. */
            .fluid-centered {
                margin-left: auto !important;
                margin-right: auto !important;
            }

            /* What it does: Forces table cells into full-width rows. */
            .stack-column=2C
            .stack-column-center {
                display: block !important;
                width: 100% !important;
                max-width: 100% !important;
                direction: ltr !important;
            }
            /* And center justify these ones. */
            .stack-column-center {
                text-align: center !important;
=09
            }

            /* What it does: Generic utility class for centering. Useful f=
or images=2C buttons=2C and nested tables. */
            .center-on-narrow {
                text-align: left !important;
                display: block !important;
                margin-left: auto !important;
                margin-right: auto !important;
                float: none !important;
=09=09=09=09}
            table.center-on-narrow {
                display: inline-block !important;
            }

        }

    </style>
    </head>
    <body bgcolor=3D"#ffffff" width=3D"100%" style=3D"margin: 0;" yahoo=3D=
"yahoo">
    <table bgcolor=3D"#ffffff" cellpadding=3D"0" cellspacing=3D"0" border=
=3D"0" height=3D"100%" width=3D"100%" style=3D"border-collapse:collapse;">
      <tr>
        <td><center style=3D"width: 100%;">

            <!-- Visually Hidden Preheader Text : BEGIN -->
            <div style=3D"display:none;font-size:1px;line-height:1px;max-h=
eight:0px;max-width:0px;opacity:0;overflow:hidden;mso-hide:all;font-family=
: sans-serif;"> Influenza incidence and what it will mean for testing in t=
his respiratory virus season is a wild card=2C as is how SARS-CoV-2 will e=
volve. </div>
            <!-- Visually Hidden Preheader Text : END -->

            <!-- Email Header : BEGIN -->
            <table align=3D"center" width=3D"600" class=3D"email-container=
">
            <tr>
                <td style=3D"padding: 20px 0px 10px 0px; text-align: cente=
r"><a href=3D"https://captodayonline.us2.list-manage.com/track/click?u=3D9=
3f21bea2e282733bd0cd8d59&id=3Db9deb428c7&e=3D3507c8b6d9"><img src=3D"http=
s://www.captodayonline.com/2022/eNEWS/Template/CAPTODAYLogo.jpg" width=3D"=
400" height=3D"102" alt=3D"alt_text" border=3D"0"></a></td>
              </tr>
=09=09=09=09
=09=09=09=09
=09=09=09=09<tr><td style=3D"padding-bottom:10px; text-align: center; font=
-family: sans-serif; font-size: 18px; mso-height-rule: exactly; line-heigh=
t: 18px; color: #555555;">Your Respiratory reCAP</td></tr>
=09=09=09=09
=09=09=09=09
          </table>
            <!-- Email Header : END -->

            <!-- Email Body : BEGIN -->
            <table cellspacing=3D"0" cellpadding=3D"0" border=3D"0" align=
=3D"center" bgcolor=3D"#ffffff" width=3D"600" class=3D"email-container">


            <!-- 1 Column Text : BEGIN -->
            <tr>
                        <td dir=3D"ltr" valign=3D"top" style=3D"font-famil=
y: sans-serif; font-size: 13px; mso-height-rule: exactly; line-height: 18p=
x; color: #555555; padding: 30px 20px 0px 20px; text-align: left;" class=
=3D"center-on-narrow"><h2>Webinar: <br><a href=3D"https://captodayonline.u=
s2.list-manage.com/track/click?u=3D93f21bea2e282733bd0cd8d59&id=3D9a460d74=
98&e=3D3507c8b6d9">&ldquo;What&#39;s Next? Transitioning from EUA to IVD=
 for SARS-CoV-2&rdquo;</a></h2>

This webinar recording provides laboratories a manufacturer-agnostic=2C CA=
P and NY State perspective on the transition from EUA to 510k assays for S=
ARS-CoV=E2=80=932. The focus is on moderate and high complexity=2C molecul=
ar microbiology laboratories to help labs begin thinking through scenarios=
 and important considerations for these upcoming transitions.<br>
<br>
Viewers will:
<ul><li>Develop an understanding of EUA and IVD regulations</li>
<li>Review validation requirements for EUA and IVD assays=2C including mod=
ified EUAs/IVDs</li>
<li>Hear discussion about the process for transitioning to IVD assays from=
 EUA assays. </li></ul><br>
Speakers:<br>
<strong>David Peaper=2C MD=2C Ph.D. </strong><br>
Associate Professor or Laboratory Medicine; Director=2C Clinical Microbiol=
ogy Laboratory=2C YNHH; Director Medical Microbiology Fellowship Program;=
 Director=2C Virology Reference Laboratory VACT<br>
<br>
<strong>Kimberlee Musser=2C Ph.D. </strong><br>
New York State Department of Health Wadsworth Center=2C David Axelrod Inst=
itute<br>
                            <br>

                           </td>
                      </tr>
=09=09=09=09<tr><td style=3D"padding:0px 20px 0px 20px"><hr style=3D"borde=
r: 1px solid #f4f4f4;"></td></tr>
=09=09=09=09
            <!-- Thumbnail Left=2C Text Right : BEGIN -->
            <tr>
                <td dir=3D"ltr" align=3D"center" valign=3D"top" width=3D"1=
00%" style=3D"padding: 25px 10px 10px 10px;"><table align=3D"center" borde=
r=3D"0" cellpadding=3D"0" cellspacing=3D"0" width=3D"100%">
                    <tr>
                    <td width=3D"56.00%" class=3D"stack-column-center"><ta=
ble align=3D"center" border=3D"0" cellpadding=3D"0" cellspacing=3D"0" widt=
h=3D"100%">
                       <tr>
                        <td dir=3D"ltr" valign=3D"top" style=3D"padding: 0=
 10px;"><a href=3D"https://captodayonline.us2.list-manage.com/track/click?=
u=3D93f21bea2e282733bd0cd8d59&id=3Dca9121d620&e=3D3507c8b6d9" target=3D"_=
blank"><img src=3D"https://www.captodayonline.com/2022/eNEWS/103122_Roche/=
301-2022LabManagerAudienceBanner300x250.jpg" width=3D"300" height=3D"250"=
 alt=3D"alt_text" border=3D"0" class=3D"fluid"></a></td>
                      </tr>
                      </table></td>
                    <td width=3D"44.00%" valign=3D"top" class=3D"stack-col=
umn-center"><table align=3D"center" border=3D"0" cellpadding=3D"0" cellspa=
cing=3D"0" width=3D"100%">
                        <tr>
                        <td dir=3D"ltr" valign=3D"top" style=3D"font-famil=
y: sans-serif; font-size: 12px; mso-height-rule: exactly; line-height: 18p=
x; color: #555555; padding: 10px; text-align: left;" class=3D"center-on-na=
rrow"><a href=3D"https://captodayonline.us2.list-manage.com/track/click?u=
=3D93f21bea2e282733bd0cd8d59&id=3D0657677744&e=3D3507c8b6d9"><h2>Roche re=
ceives EUA for Cobas SARS-CoV-2 Duo</h2></a>
Roche announced that the FDA issued emergency use authorization for the Co=
bas SARS-CoV-2 Duo for use on the fully automated Cobas 6800/8800 systems.=
 The real-time RT-PCR assay is for the in vitro qualitative and quantitati=
ve detection of SARS-CoV-2 RNA in nasal and nasopharyngeal swab specimens.=
 <br>
                            <br>
                         </td>
                      </tr>
                      </table></td>
                  </tr>
                  </table></td>
              </tr>
            <!-- Thumbnail Left=2C Text Right : END -->
           <tr><td style=3D"padding:10px 20px 0px 20px"><hr style=3D"borde=
r: 1px solid #f4f4f4;"></td></tr>
            <!-- Thumbnail Right=2C Text Left : BEGIN -->
=09=09=09
            <tr>
                <td dir=3D"rtl" align=3D"center" valign=3D"top" width=3D"1=
00%" style=3D"padding: 10px;"><table align=3D"center" border=3D"0" cellpad=
ding=3D"0" cellspacing=3D"0" width=3D"100%">
                    <tr>
                    <td width=3D"33.33%" class=3D"stack-column-center"><ta=
ble align=3D"center" border=3D"0" cellpadding=3D"0" cellspacing=3D"0" widt=
h=3D"100%">
                        <tr>
                        <td dir=3D"ltr" valign=3D"top" style=3D"padding: 2=
0px 10px;"><a href=3D"https://captodayonline.us2.list-manage.com/track/cli=
ck?u=3D93f21bea2e282733bd0cd8d59&id=3Dc01a137e4c&e=3D3507c8b6d9" target=
=3D"_blank"><img src=3D"https://www.captodayonline.com/2022/eNEWS/103122_R=
oche/301-2022LabManagerAudienceBanner160x600.jpg" width=3D"160" height=3D"=
600px" alt=3D"Roche: Better Retirement" border=3D"0" class=3D"center-on-na=
rrow"></a></td>
                      </tr>
                      </table></td>
                    <td width=3D"66.66%" valign=3D"top" class=3D"stack-col=
umn-center"><table align=3D"center" border=3D"0" cellpadding=3D"0" cellspa=
cing=3D"0" width=3D"100%">
                        <tr>
                <td style=3D"padding: 0px 20px 10px 10px; text-align: left=
; font-family: sans-serif; font-size: 12px; mso-height-rule: exactly; line=
-height: 18px; color: #555555;"><a href=3D"https://captodayonline.us2.list=
-manage.com/track/click?u=3D93f21bea2e282733bd0cd8d59&id=3Ddfb7ac3282&e=3D=
3507c8b6d9"><h1>A wait-and-watch season of respiratory viruses</h1></a>
=09=09=09=09=09
=09=09=09=09=09Influenza incidence and what it will mean for testing in th=
is respiratory virus season is a wild card=2C as is how SARS-CoV-2 will ev=
olve. In early September=2C SARS-CoV-2 prevalence was declining in parts o=
f the United States. =E2=80=9CAnd if you believe in the theory of viral in=
terference=2C=E2=80=9D says Michelle Tabb=2C PhD=2C chief scientific offic=
er at DiaSorin Molecular=2C =E2=80=9Cit=E2=80=99s leaving the door wide op=
en right now for something else to step in. We=E2=80=99ll see if that=E2=
=80=99s RSV=2C or flu A=2C or if it=E2=80=99s a new COVID variant.=E2=80=
=9D<br><br>
Australia saw an early peak in influenza and the highest it has seen in ab=
out half a decade=2C simultaneous with COVID=2C says David Persing=2C MD=
=2C PhD=2C chief scientific officer at Cepheid. Public health advisors wor=
ry the same could happen in the Northern Hemisphere. =E2=80=9CThe concern=
 is we=E2=80=99re going to have a surge in influenza and an ongoing level=
 of COVID activity that will combine to create a pretty consequential resp=
iratory season=2C=E2=80=9D Dr. Persing says. Furthermore=2C with fewer exp=
osed to influenza over the past two years=2C =E2=80=9Cthe lack of natural=
 immunity could create a condition in which we have more severe cases=2C o=
r more cases overall=2C and that=E2=80=99s what everybody is afraid of.=E2=
=80=9D<br><br>
Australia=E2=80=99s statistics=2C while concerning=2C could reflect some a=
mount of ascertainment bias=2C says Daniel Rhoads=2C MD=2C assistant profe=
ssor and section head of microbiology at the Cleveland Clinic. =E2=80=9CPe=
ople are getting tested more now than they did pre-COVID when they have a=
 respiratory virus=2C=E2=80=9D he says. =E2=80=9CSo I think we=E2=80=99re=
 going to detect more influenza=2C and we have to keep in mind that increa=
sed testing is going to lead to increased detection.=E2=80=9D
=09=09=09=09
             </td>
              </tr>
                      </table></td>
                  </tr>
                  </table></td>
              </tr>
            <!-- Thumbnail Right=2C Text Left : END -->

          </table>
            <!-- Email Body : END -->

            <!-- Email Footer : BEGIN -->
            <table align=3D"center" width=3D"600" class=3D"email-container=
">
            <tr>
                <td style=3D"padding: 40px 10px;width: 100%;font-size: 12p=
x; font-family: sans-serif; mso-height-rule: exactly; line-height:18px; te=
xt-align: center; color: #888888;">
                <br>
                <br>
                =C2=A9 2022 CAP TODAY=2C all rights reserved. The appearan=
ce of advertising in this message is not a CAP guarantee or endorsement of=
 the product or the claims made for the product by the manufacturer.<br>
                </td>
              </tr>
          </table>
            <!-- Email Footer : END -->

          </center></td>
      </tr>
    </table>
            <center>
                <br>
                <br>
                <br>
                <br>
                <br>
                <br>
                <table border=3D"0" cellpadding=3D"0" cellspacing=3D"0" wi=
dth=3D"100%" id=3D"canspamBarWrapper" style=3D"background-color:#FFFFFF; b=
order-top:1px solid #E5E5E5;">
                    <tr>
                        <td align=3D"center" valign=3D"top" style=3D"paddi=
ng-top:20px; padding-bottom:20px;">
                            <table border=3D"0" cellpadding=3D"0" cellspac=
ing=3D"0" id=3D"canspamBar">
                                <tr>
                                    <td align=3D"center" valign=3D"top" st=
yle=3D"color:#606060; font-family:Helvetica=2C Arial=2C sans-serif; font-s=
ize:11px; line-height:150%; padding-right:20px; padding-bottom:5px; paddin=
g-left:20px; text-align:center;">
                                        This email was sent to <a href=3D"=
mailto:gloria@caldonbiotech.com" target=3D"_blank" style=3D"color:#404040 !importa=
nt;">gloria@caldonbiotech.com</a>
                                        <br>
                                        <a href=3D"https://captodayonline.=
us2.list-manage.com/about?u=3D93f21bea2e282733bd0cd8d59&id=3D1abd017e9e&e=
=3D3507c8b6d9&c=3Da959238978" target=3D"_blank" style=3D"color:#404040 !impo=
rtant;"><em>why did I get this?</em></a>&nbsp;&nbsp;&nbsp;&nbsp;<a href=3D=
"https://captodayonline.us2.list-manage.com/unsubscribe?u=3D93f21bea2e2827=
33bd0cd8d59&id=3D1abd017e9e&e=3D3507c8b6d9&c=3Da959238978" style=3D"color:#4=
04040 !important;">unsubscribe from this list</a>&nbsp;&nbsp;&nbsp;&nbsp;<=
a href=3D"https://captodayonline.us2.list-manage.com/profile?u=3D93f21bea2=
e282733bd0cd8d59&id=3D1abd017e9e&e=3D3507c8b6d9&c=3Da959238978" style=3D"col=
or:#404040 !important;">update subscription preferences</a>
                                        <br>
                                        CAP TODAY &middot; 325 Waukegan Ro=
ad &middot; Northfield=2C IL 60093 &middot; USA
                                        <br>
                                        <br>

                                    </td>
                                </tr>
                            </table>
                        </td>
                    </tr>
                </table>
                <style type=3D"text/css">
                    @media only screen and (max-width: 480px){
                        table#canspamBar td{font-size:14px !important;}
                        table#canspamBar td a{display:block !important; ma=
rgin-top:10px !important;}
                    }
                </style>
            </center><img src=3D"https://captodayonline.us2.list-manage.co=
m/track/open.php?u=3D93f21bea2e282733bd0cd8d59&id=3Da959238978&e=3D3507c8b6d9" height=3D"1" width=3D"1" alt=3D""></body>
</html>
--_----------=_MCPart_2086185115--
